These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 28866005

  • 1. Discrete memory impairments in largely pure chronic users of MDMA.
    Wunderli MD, Vonmoos M, Fürst M, Schädelin K, Kraemer T, Baumgartner MR, Seifritz E, Quednow BB.
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005
    [Abstract] [Full Text] [Related]

  • 2. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL, Hamilton C, Kennedy DO, Scholey AB.
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [Abstract] [Full Text] [Related]

  • 3. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 4. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ.
    Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
    [Abstract] [Full Text] [Related]

  • 5. Neuropsychological function in ecstasy users: a study controlling for polydrug use.
    Roiser JP, Rogers RD, Sahakian BJ.
    Psychopharmacology (Berl); 2007 Jan; 189(4):505-16. PubMed ID: 16163532
    [Abstract] [Full Text] [Related]

  • 6. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 7. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M.
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [Abstract] [Full Text] [Related]

  • 8. A prospective study of learning, memory, and executive function in new MDMA users.
    Wagner D, Becker B, Koester P, Gouzoulis-Mayfrank E, Daumann J.
    Addiction; 2013 Jan; 108(1):136-45. PubMed ID: 22831704
    [Abstract] [Full Text] [Related]

  • 9. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
    Downey LA, Sands H, Jones L, Clow A, Evans P, Stalder T, Parrott AC.
    Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
    [Abstract] [Full Text] [Related]

  • 10. Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression.
    Zacher A, Zimmermann J, Cole DM, Friedli N, Opitz A, Baumgartner MR, Steuer AE, Verdejo-Garcia A, Stock AK, Beste C, Quednow BB.
    Eur Neuropsychopharmacol; 2024 Jun; 83():43-54. PubMed ID: 38642447
    [Abstract] [Full Text] [Related]

  • 11. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC.
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [Abstract] [Full Text] [Related]

  • 12. Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users.
    Blagrove M, Seddon J, George S, Parrott AC, Stickgold R, Walker MP, Jones KA, Morgan MJ.
    J Psychopharmacol; 2011 Apr; 25(4):465-77. PubMed ID: 20615932
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 17. Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users.
    Dafters RI, Hoshi R, Talbot AC.
    Psychopharmacology (Berl); 2004 May; 173(3-4):405-10. PubMed ID: 12955295
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ.
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [Abstract] [Full Text] [Related]

  • 20. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.